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Background and aim: Genetic factors regulating alcohol metabolism could
predispose in developing alcoholic pancreatitis (ACP). Studies revealed that alcohol
could be metabolized by both ways, oxidative and non-oxidative. The main oxidative
pathway includes alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH), and
cytochrome P450 enzyme. We investigated the association of polymorphisms in these
enzymes with the alcoholic pancreatitis in the north Indian population.
Method: Patients with alcoholic pancreatitis (ACP; n = 72), tropical calcific pancreatitis
(TCP; n = 75), alcoholic controls (AC; n = 40), and healthy controls (HC; n = 100) were
included in the study. Blood samples were collected from the subjects in EDTA coated
vials. DNA was extracted and genotyping for ADH3, ALDH2, and CYP2E1 was done by
PCR-RFLP (polymerase chain reaction—restriction fragment length polymorphism). The
products were analyzed by gel electrophoresis.
Result: The frequency distribution of ADH3∗1/∗1 genotype was significantly higher
in ACP group (59.7%) compared with TCP (38.7%), HC (42%), and AC (37.5%) and
was found to be associated with increased risk of alcoholic pancreatitis. There was
no statistically significant difference between the frequency distribution of ADH3∗1/∗1,
ADH3∗1/∗2, and ADH3∗2/∗2 genotypes between TCP and HC or healthy alcoholics.
ALDH2 gene wasmonomorphic in our population, and the frequencies for CYP2E1 intron
6 Dra I polymorphism were comparable in all the four groups.
Conclusion: This study shows that carriers of ADH3∗1/∗1 individuals consuming alcohol
are at higher risk for alcoholic pancreatitis than those with other genotypes such as
ADH3∗1/∗2 and ADH3∗2/∗2.
Keywords: chronic pancreatitis, genetic polymorphism, alcohol dehydrogenase
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INTRODUCTION
Alcohol tolerance is highly dependent on the presence or
absence of alcohol metabolizing enzymes and the subjects having
history of alcohol consumption are more susceptible for chronic
pancreatitis onset (Czech and Hartleb, 2003; Cichoz-Lach et al.,
2008). Alcohol consumption is suggested to be a major cause
of chronic pancreatitis in 70–80% cases in developed countries
(Singh and Simsek, 1990; Dzienizewski and Gabryelewicz, 2003;
Cichoz-Lach et al., 2008). Genetic factors regulating alcohol
metabolism could play a role in developing alcoholic pancreatitis
(Vonlaufen et al., 2007). Although these factors are critical
in the etiology of chronic pancreatitis, their role in alcoholic
pancreatitis is not clearly elucidated.
Alcohol is mainly oxidized by oxidative pathway. The
major enzyme of oxidative pathway of alcohol metabolism is
alcohol dehydrogenase (ADH)- a dimeric Zn-containing protein
with a subunit molecular weight of 40 kDa, and aldehyde
dehydrogenase (ALDH; Quertemont, 2004; Edenberg, 2007).
ADH is encoded by at least seven gene loci located on the
long arm of chromosome 4 (chromosome 4q22) in which
ADH2 (ADH1B) and ADH3 (ADH1C) are highly polymorphic
(Edenberg, 2000, 2007). ADH3 gene has two alleles ADH3∗1,
ADH3∗2 encoding subunits γ1 (Arginine at position 272 and
isoleucine at position 350), and γ2 (glutamine at position 272
and a valine at position 350), respectively (Edenberg, 2007).
The subunit γ1 shows higher ethanol activity than the subunit
γ
2 (Day et al., 1991; Crabb et al., 1993; Edenberg, 2007). In
majority of cases the occurrence of these two SNPs have been
observed, indicating very high linkage disequilibrium (Edenberg,
2007). The turnover rate of ADH depends on the association
of the subunits and the homodimeric enzyme γ1γ1 have
substantially higher rate (70%) than γ2γ2 enzyme (Edenberg,
2007). Additionally, ADH3, which encodes a subunit with
threonine at position 352 (ADH1C∗Thr352) has been described
in the Native Americans, however, the protein have not been
properly investigated (Osier et al., 2002; Edenberg, 2007).
Alcohol is first metabolized to acetaldehyde by ADH and
then to acetate by ALDH. Four different isozymes of ALDH;
ALDH1, ALDH2, ALDH3, andALDH4 are found predominantly
in the liver and can be differentiated with respect to kinetic
properties, localization within the cell, tissue distribution,
and electrophoretic mobility (Greenfield and Pietruszko, 1977;
Harada et al., 1980; Duley et al., 1985). ALDH2 isozyme
is located in mitochondria and is the principal enzyme for
acetaldehyde metabolism. ALDH2 is located on the chromosome
12 (chromosome 12q24.2) and is polymorphic with two
alleles: ALDH2∗1 and ALDH2∗2 with ethnic differences in the
polymorphisms and different kinetic properties (Day et al., 1991;
Edenberg, 2007).
Moreover, the involvement of Cytochrome P450s (CYPs) has
been also implicated in the alcohol metabolism and associated
disease progression (Burim et al., 2004; Liu et al., 2007). CYP2E1
is a key microsomal enzyme that metabolizes alcohol in the
non-alcohol dehydrogenase pathway (Ingelman-Sundberg et al.,
1993; Song, 1996; Liu et al., 2007). Since, CYP2E1 is ethanol
inducible and highly polymorphic, it is inevitable to investigate
polymorphism in this gene, which may explain the variation
in disease causation by alcohol. One important polymorphism
of CYP2E1 in the intron 6 region, Dra I polymorphism, has
been found to be associated with chronic pancreatitis (Ingelman-
Sundberg et al., 1993; Song, 1996).
Polymorphisms in alcohol metabolizing enzyme genes have
been found to be associated with alcoholic liver disease (Khan
et al., 2009, 2010); however, not much information regarding the
role of alcohol metabolizing genes polymorphisms in pancreatitis
in the north Indian population is available. Evidence from
epidemiological, laboratory, and clinical studies suggest that
only about 5–10% alcoholics suffer from clinically recognized
CP (Bisceglie and Segal, 1984; Harber et al., 1995; Perri et al.,
2003). This variation in disease causation suggests that there
could be differences in underlying genetic susceptibility. It can
be speculated that polymorphism in these alcohol metabolizing
enzyme genes could predispose subjects consuming alcohol
to alcoholic pancreatitis. Therefore, the aim of the present
study is to investigate the association of ADH3, ALDH2, and
CYP2E1 polymorphisms in alcoholic pancreatitis in North
Indian population.
SUBJECTS AND METHODS
Subjects
All consecutive patients with pancreatitis attending the
Pancreatobiliary Clinic at Sanjay Gandhi Post Graduate Institute
of Medical Sciences, Lucknow were included in the study as
per inclusion criteria. Diagnosis was based on clinical and
radiological criteria. Inclusion criteria for tropical pancreatitis
were radiological evidence of pancreatic intraductal calculi,
no history of alcohol consumption and no family history of
Pancreatitis. However, inclusion criteria for alcoholic pancreatitis
were history of >80 g of alcohol ingestion for at least 3 years,
radiological evidence of pancreatitis, increased serum amylase,
and absence of any other cause for pain (Table 1). Alcohol
consumption history was taken in a questionnaire. Almost all
the patients in both the group (ACP and TCP) had pain at
presentation. The pain was epigastric in nature usually radiating
TABLE 1 | The inclusion and exclusion criteria for the recruitment of
subjects for the study.
Inclusion criteria Exclusion criteria
ACP 1. History of >80g of alcohol
intake for at least 3 years
2. Radiological evidence of
pancreatitis (acute or chronic)
3. Increased serum amylase
4. Absence of any other cause for
pain
1. Presence of pancreatic cancer
2. Occasional alcohol intake
TCP 1. Radiological evidence of
pancreatic intraductal calcification
2. Non-alcoholic
3. No family history of Pancreatitis
1. Presence of any other etiological
factor like alcoholism, gall stones
hypercalcaemia etc.
2. Presence of pancreatic cancer
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to back. Frequency of diabetes in TCP group was 28% (21/75)
and in ACP group 18.5% (13/72). The main clinical feature in
ACP group was presence of pseudopancreatic cyst. It was present
in 41.7% (30/72) of the alcoholic pancreatitis patients. History of
alcohol intake was taken in all the patients. None of the patients
in TCP group had history of alcohol consumption. In brief, 72
patients with alcoholic pancreatitis, 75 patients with tropical
calcific pancreatitis (TCP), 100 healthy controls (HC), and 40
alcoholic controls (AC) free from any gastrointestinal disorder
were recruited in the study (Table 2). Cases and controls were
from the same ethnic group and were residents of the northern
parts of India. The ethics committee of the institution approved
the study. A written pre-informed consent was obtained prior to
blood collection from the individuals.
Method
DNA Isolation
Blood sample was collected from each subject in EDTA coated
vial. Genomic DNA was extracted by phenol chloroform method
previously described (Miller et al., 1998). The purity and integrity
of genomic DNA were checked on agarose gel (0.8%) and by
calculating the ratio of absorbance at 260/280 nm (1.8–2.0). The
DNA content was quantified by absorbance at 260 nm (1.00
optical density was considered equivalent to 50 mg/mL genomic
DNA) before PCR amplification. DNA samples were stored at
−80◦C till further use.
GENOTYPING
Genotyping for ADH3 Polymorphism
DNA was amplified with specific oligonucleotide primers. The
forward and reverse primers were 5′ GCTTTAAGAGTAAAT
ATTCTGTCCC 3′ and 5′ AATCTACCTCTTTCCGAAGC 3′,
respectively. PCR amplification was performed in 25µl reaction
mixture using the standardized PCR condition. The PCR
condition included initial denaturation at 95◦C for 5min
followed by 35 cycles of denaturation, annealing, and extension
at 94◦C for 30 s, 55◦C for 30 s, and 72◦C for 30 s, respectively.
Final extension was done at 72◦C for 10min. The 145 bp ADH3
amplicons were digested with SspI restriction enzyme at 37◦C
for overnight. Genotyping was done by analyzing bands on 12%
PAGE. ADH31−1 genotype: two bands (67 and 63 bp), ADH31−2
genotype: three bands (∼130, 67, and 63 bp), ADH32−2 genotype:
one band (130 bp). A 15 bp cut was also present and not
visualized on gel (Groppi et al., 1990).
TABLE 2 | Age and Gender distribution.
Characteristics ACP TCP HC AC
N 72 75 100 40
Sex (male/female) All male 40/35 60/40 All male
Age (mean ± SD) in years 38.5 ± 8.3 32.8 ± 11.2 32.05 ± 4.6 35.9 ± 5.3
ACP, alcoholic chronic pancreatitis; TCP, tropical calcific pancreatitis; HC, healthy control;
AC, alcoholic control.
Genotyping for ALDH2 Polymorphism
ALDH2 genotyping was done by PCR-RFLP. The forward and
reverse primers were 5′ CAAATTACAGGGTCAAGGGCT 3′
and 5′ CCACACTCACAGTTTTCTCTT 3′, respectively. PCR
was done using standardized PCR condition. The PCR condition
included initial denaturation at 95◦C for 3min followed by
35 cycles of denaturation, annealing, and extension at 94◦C
for 15 s, 59.7◦C for 45 s, and 72◦C for 30 s, respectively.
Final extension was done at 72◦C for 10min. The 134
bp ALDH2 amplicons were digested with MboII restriction
enzyme at 37◦C for overnight. Genotyping was done by
analyzing bands on 12% PAGE. ALDH21−1 genotype: one
band (125 bp), ALDH21−2 genotype: two bands (125 and 134
bp), ALDH22−2 genotype: one band (134 bp; Muto et al.,
2000).
Genotyping for CYP2E1 Intron 6 (Dra I)
Polymorphism
Polymorphism in the intron 6 of CYP2E1 was determined
by PCR-RFLP method. Enzyme Dra I was used to detect
the D and C polymorphism in intron 6. The specific
primers were 5′ TCGTCAGTTCCTGAAAGCAGG 3′ and 5′
GAGCTCTGATGGAAGTATCGCA 3′. The PCR condition were
initial denaturation at 95◦C for 4min followed by 40 cycles
of denaturation, annealing, and extension at 94◦C for 1min,
60.4◦C for 45 s, and 72◦C for 3min, respectively. Final extension
was done at 72◦C for 10min. The 995 bp amplified product
was then digested with Dra I restriction enzyme at 37◦C for
15–16 h. Genotyping was done on 3% agarose gel stained with
ethidium bromide. DD genotype: three bands (572, 302, and
121 bp), CD genotype four bands (874, 572, 302, and 121 bp), CC
genotype: two bands (874 and 121 bp; Kato et al., 1994; Wu et al.,
1998).
STATISTICAL ANALYSIS
Genotypic frequencies were calculated and odds ratios (OR) were
determined by 2 × 2 contingency table with 95% confidence
intervals. Statistical significance for OR was calculated by
chi-square test using SPSS Version 12 software. Fisher exact
test was used, when expected cell frequency was less than
five. Age and sex adjusted OR were calculated to assess the
disease risk.
RESULTS
The mean age and sex distribution are shown in the table
(Table 2). Mean age of ACP patients was higher in comparison
to TCP patients. Sex distribution in the studied groups was
dissimilar as ACP and healthy alcoholics groups consist of
males only.
ADH3 Polymorphism
Frequency of ADH3∗1/ADH3∗1, ADH3∗1/ADH3∗2, and
ADH3∗2/ADH3∗2 genotypes were 59.7 (43/72), 30.6 (22/72), and
9.7% (7/72), respectively in ACP group (Table 3; Figures 1A,B).
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The prevalence of ADH3∗1/ADH3∗1 genotype was higher in
ACP group in comparison to TCP, AC, and HC groups. The
genotype frequency of ADH3∗1/ADH3∗1 was significantly
higher in alcoholic pancreatitis in comparison to HC (p = 0.01;
OR = 2.6; 95% CI = 1.2–5.7) and AC (p = 0.02; OR = 2.4; 95%
CI = 1.1–5.4). The genotype frequency of ADH3∗1/ADH3∗1
was also significantly high in ACP group in comparison to TCP
(p = 0.01, OR= 2.3; 95% CI= 1.2–4.5) group (Table 4).
The prevalence of ADH3∗1/ADH3∗1 genotype was 38.7%
(29/75) in TCP group. Frequency of ADH3∗1/ADH3∗2 and
ADH3∗2/ADH3∗2 genotype were 53.3 (40/75) and 8% (6/75),
respectively in TCP group. ADH3∗1/ADH3∗1 genotype
frequency in TCP group was comparable with HC and AC
groups. Frequencies of both heterozygous ADH3∗1/ADH3∗2
genotype and homozygous ADH3∗2/ADH3∗2 genotype
were statistically similar in TCP, HC, and AC groups
(Table 3).
ALDH2 and CYP2E1 Polymorphisms
ALDH2 is an alcohol metabolizing enzyme and polymorphism
in this enzyme may affect individual susceptibility to develop
the disease (Quertemont, 2004). We performed PCR-RFLP
for ALDH2 in 90 patients (ACP: 50, TCP: 40) and 40 each
alcoholic (AC) and healthy controls (HC) and found that all
were monomorphic having ALDH2∗1/ALDH2∗1 homozygote
TABLE 3 | Summary of frequency distribution of ADH3 genotypes.
Genotype ACP (n = 72) TCP (n = 75) HC (n = 100) AC (n = 40)
ADH3*1/*1 43 (59.7%) 29 (38.7%) 42 (42%) 15 (37.5%)
ADH3*1/*2 22 (30.6%) 40 (53.3%) 50 (50%) 22 (55%)
ADH3*2/*2 07 (9.7%) 6 (8%) 08 (8%) 03 (7.5%)
ACP, alcoholic chronic pancreatitis; HC, healthy control; AC, alcoholic control; TCP,
tropical chronic pancreatitis.
genotype. Additionally, we studied the CYP2E1 intron 6 Dra I
polymorphism. In ACP group frequency of DD, CD, and CC
genotypes were approximately 85% (61/72), 14% (10/72) and
1.4% (1/72), respectively. Frequency of DD and CD genotypes
were 84 (63/75) and 16% (12/75), respectively in TCP group.
Frequency distribution of CYP2E1 genotype is statistically
similar in all the studied groups (Table 5).
DISCUSSION
Alcohol misuse is now an established cause of chronic
pancreatitis (Verlaan et al., 2004), and therefore the
understanding of alcohol metabolism, its regulation, and
polymorphisms of the alcohol metabolizing enzymes could
be critical for the etiopathogenesis of ACP. There are various
determinants of polymorphism, such as, age, sex, location,
ethnicity, and race. ADH3, which is involved in the alcohol
metabolism, has two alleles ADH3∗1 and ADH3∗2 (Edenberg,
2007). Since, ADH3∗1/ADH3∗1 genotype encodes for the
fast metabolizing enzyme, the subjects carrying this genotype
can metabolize ethanol at much faster rate resulting in rapid
formation of acetaldehyde (Edenberg, 2007). To retain dynamic
homeostasis, the conversion of acetaldehyde to acetate with
same pace is essential. Malfunctioning of these proteins due to
any mutation may lead the accumulation of acetaldehyde that
may account for the disease causation (Majumdar et al., 1986;
Nordback et al., 1991; Vonlaufen et al., 2007).
We observed strong association of ADH3∗1/ADH3∗1
genotype with alcoholic pancreatitis (Tables 3, 4; ACP vs. HC:
p = 0.01; OR = 2.6; 95% CI = 1.2–5.7 and ACP vs. AC:
p = 0.02; OR = 2.4; 95% CI = 1.1–5.4). Studies conducted
in past on other populations worldwide have demonstrated
varying results—some showing strong association of ADH3
polymorphism with ACP (Day et al., 1991; Dumas et al., 1995),
some showing either statistically insignificant or no association
of ADH3 polymorphism with ACP (Frenzer et al., 2002; Verlaan
FIGURE 1 | (A) Polyacrylamide gel image of PCR amplicons and RFLP by-products of ADH3 gene: Lane1, ADH3*1/ADH3*2; Lane 2, ADH3*1/ADH3*1; Lane 3,
ADH3*2/ADH3*2. We observed two bands (67 and 63bp) for ADH31−1, three bands (∼130, 67, and 63bp) for ADH31−2 and one band (130bp) for ADH32−2
genotypes. Our result suggest that ADH3*1/1 genotypes are more frequent in ACP group in comparison to AC, HC, and TCP and that the carriers of ADH3*1/1
genotype are at higher risk for ACP. (B) Bar diagram representation of frequency distribution of ADH3 genotypes in ACP, TCP, HC, and AC groups.
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TABLE 4 | Summary of analysis of ADH3 frequency data.
Groups ACP vs. TCP ACP vs. HC ACP vs. AC TCP vs. HC TCP vs. AC HC vs. AC
p-value OR
(95% CI)
p-value OR
(95% CI)
p-value OR
(95% CI)
p-value OR
(95% CI)
p-value OR
(95% CI)
p-value OR
(95% CI)
ADH31−2 vs.
ADH31−1 (ref)
0.06; 0.37
(0.18–0.74)
0.01; 0.43
(0.22–0.88)
0.01; 0.34
(0.15–0.8)
0.6; 1.1
(0.61–2.17)
0.88; 0.94
(0.41–2.11)
0.59; 1.2
(0.56–2.6)
ADH32−2 vs.
ADH31−1(ref)
0.69; 0.78
(0.24–2.5)
0.72; 0.85
(0.28–2.5)
0.78; 0.81
(0.18–3.5)
0.88; 1.0
(0.34–3.4)
0.96; 1.0
(0.22–4.7)
0.94; 1.0
(0.24–4.4)
ADH31−1 vs. carriers
of ADH3*2 (ref)
0.01*; 2.3
(1.2–4.5)
0.01*; 2.6
(1.2–5.7)
0.02*; 2.4
(1.1–5.4)
0.7; 0.89
(0.48–1.6)
0.9; 1.0
(0.47–2.3)
0.67; 0.84
(0.39–1.8)
ACP, alcoholic chronic pancreatitis; TCP, tropical calcific pancreatitis; HC, healthy control; AC, alcoholic control; OR, odds ratio; CI, confidence interval.
TABLE 5 | CYP2E1 frequency data.
Genotype ACP (n = 72) TCP (n = 75) HC (n = 90) AC(n = 40)
CC 1 (1.4%) 0 0 0
CD 10 (14%) 12 (16%) 22 (24%) 07 (17.5%)
DD 61 (85%) 63 (84%) 68 (76%) 33 (82.5%)
P-VALUE AND OR (95% CI)
ACP vs. TCP ACP vs. HC ACP vs. AC TCP vs. HC TCP vs. AC HC vs. AC
CD 0.9; 1 (0.27–3.7) 0.08; 0.4 (0.14–1.1) 0.5; 0.67 (0.21–3.1) 0.1; 0.5 (0.25–1.2) 0.3; 0.5 (0.1–1.9) 0.3; 0.63 (0.22–1.7)
DD (Ref) Reference Reference Reference Reference Reference Reference
ACP, alcoholic chronic pancreatitis; TCP, tropical calcific pancreatitis; HC, healthy control; AC, alcoholic control; OR, odds ratio; CI, confidence interval.
et al., 2004). This could be explained as association of ADH3
polymorphism and ACP risk highly depends on the ethnicity
therefore could vary from one population to another or one
ethnic group to another depending upon the localities they
occupy and lifestyle factor.
The ALDH2 gene has two alleles, ALDH2∗1 and ALDH2∗2.
Since, ALDH2 enzyme is the main form of aldehyde
dehydrogenase responsible for acetaldehyde oxidation
and polymorphism at its locus has been shown to be
associated with chronic pancreatitis (Day et al., 1991), we
also investigated ALDH2. Surprisingly, we were unable to
detect any polymorphism in ALDH2 and all the subjects were
homozygous for ALDH2∗1/ALDH2∗1 genotype. It clearly
indicates that ALDH2 gene is monomorphic in the north
Indian population and it might be possible that our population
predominantly carried ALDH2∗1 allele. Our results were in
agreement with the other finding by Bhaskar et al. in six
Indian populations, which also showed that all the subjects
had common homozygous genotype (ALDH2∗1/∗1; Bhaskar
et al., 2007). Some other studies conducted previously in Japan
and Korea have also shown variable frequency of ALDH2
among different populations (Kimura et al., 2000; Lee et al.,
2001).
Furthermore, we also investigated polymorphism of CYP2E1,
a key microsomal enzyme induced by ethanol, which metabolizes
alcohol in non-alcohol dehydrogenase pathway. We particularly
investigated CYP2E1 intron 6D polymorphism, which exhibits
two alleles: allele D and allele C. There was no significant
difference in the frequency distribution of DD or CD genotype of
CYP2E1; however, CC homozygous genotype was less frequent.
Genotype frequencies were statistically similar in all the four
groups. There was no difference observed in allele frequencies
also. The results indicate no association of intron 6 Dra I
polymorphism of CYP2E1 with tropical or alcoholic pancreatitis
in North Indian population. Our results are in agreement
with the previous reports showing no association of CYP2E1
polymorphism with alcoholic cirrhosis (Lee et al., 2001; Vidal
et al., 2004). Nevertheless, a study of CYP2E1 intron 6 Dra
I polymorphism showed a weak positive association of DD
genotype to alcoholic pancreatitis (Verlaan et al., 2004).
In conclusion, the results demonstrate that ADH3
polymorphism may be an important contributor for alcoholic
chronic pancreatitis among North Indian population. The
polymorphism of ALDH2 and CYP2E1, probably do not have
important role in ACP.
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